March 24, 2017

If you no longer wish to receive this free newsletter, CLICK HERE to unsubscribe
The ValuEngine Weekly is an Investor Education newsletter focused on the quantitative approach to
investing and the tools available from In today's fast-moving and globalized financial markets, it is easy to
get overloaded with information. The winners will adopt an objective, scientific, independent and
unemotional approach to investing. If you are not yet a member of ValuEngine's stock analysis service,
sign up now for a two-week free trial at www.valuengine.com!

If the tables, charts, or other content in this email version of the newsletter do
not display properly, please check it out at our at our blog HERE

To subscribe to our bulletins and receive content whenever it is published,

subscribe at our blog HERE

This week, we provide top-five ranked VE data for our Medical stocks. We take a look at
our latest data on Intel $INTC. We currently have an overvaluation watch underway.
VALUATION WATCH: Overvalued stocks now make up 64.57% of our stocks assigned a
valuation and 31.59% of those equities are calculated to be overvalued by 20% or more.
Fifteen sectors are calculated to be overvalued.

MARKET OVERVIEW

Index Started week Friday AM Change Change % ytd

DJIA 20916.27 20694.72 -221.55 -1.06% 4.72%
NASDAQ 5898.81 5841.32 -57.49 -0.97% 8.51%
RUSSELL 2000 1391.46 1353.43 -38.03 -2.73% -0.27%
S&P 500 2378.24 2351.45 -26.79 -1.13% 5.03%
 Summary of VE Stock Universe
Stocks Undervalued 35.43%
Stocks Overvalued 64.57%
Stocks Undervalued by 20% 14.98%
Stocks Overvalued by 20% 26.13%

SECTOR OVERVIEW
Sector Change MTD YTD Valuation Last 12-M P/E
Return Ratio
Aerospace 0.39% -2.39% 1.28% 13.52% overvalued 24.44% 19.97
Auto-Tires-Trucks 0.51% -0.71% 3.28% 6.83% overvalued 27.59% 14.33
Basic Materials 0.07% -2.20% 5.73% 4.90% overvalued 47.77% 26.81
Business Services 0.35% -0.87% 3.05% 10.20% overvalued 13.71% 24.66
Computer and Technology 0.29% 1.11% 7.85% 16.63% overvalued 23.30% 31.3
Construction 0.39% -0.49% 6.88% 10.20% overvalued 23.29% 21.34
Consumer Discretionary 0.67% 0.95% 3.87% 6.41% overvalued 17.97% 25.56
Consumer Staples 0.18% 0.65% 3.49% 10.18% overvalued 13.07% 25.08
Finance 0.47% -2.13% 1.79% 10.89% overvalued 17.76% 17.48
Industrial Products 0.86% -0.73% 2.16% 16.21% overvalued 22.49% 25.46
Medical 0.31% -1.99% 7.99% 1.74% overvalued 13.99% 27.69
Multi-Sector Conglomerates 0.57% 1.51% 6.23% 17.25% overvalued 14.12% 20.16
Oils-Energy 0.34% -4.74% -4.58% 2.16% undervalued 17.67% 30.11
Retail-Wholesale 0.51% -1.15% -1.01% 1.74% overvalued 4.12% 23.48
Transportation 0.24% -3.04% 2.24% 7.16% overvalued 14.95% 19.16
Utilities -0.02% 1.09% 2.57% 12.29% overvalued 20.04% 23.08

Sector TalkMedical
Below, we present the latest data on leading Medical Sector stocks from our
Professional Stock Analysis Service. We applied some basic liquidity criteria--share
price greater than $3 and average daily volume in excess of 100k shares. We have
been following the sector closely of late because it has been correlated so tightly to
overall equity price moves.
Top-Five Medical Sector Stocks--Short-Term Forecast Returns
Ticker Company Name Market Price Valuation Last 12-M Retrn
EGRX EAGLE PHARMACT 81.83 -6.51% 97.51%
ANIP ANI PHARMACEUT 45.54 -13.30% 38.04%
LNTH LANTHEUS HLDGS 11.9 N/A 513.40%
LCI LANNETT INC 21.2 -45.56% 4.13%
SCMP SUCAMPO PHARMAC 10.75 -30.84% 6.02%

Top-Five Medical Sector Stocks--Long-Term Forecast Returns

Ticker Company Name Market Price Valuation Last 12-M Retrn
AKAO ACHOGEN INC 20.3 223.89% 574.42%
LNTH LANTHEUS HLDGS 11.9 N/A 513.40%
EXEL EXELIXIS INC 20.31 79.04% 411.59%
CRBP CORBUS PHARMACT 9 N/A 381.28%
AERI AERIE PHARMACT 45.6 127.91% 285.79%

Top-Five Medical Sector Stocks--Composite Score

Ticker Company Name Market Price Valuation Last 12-M Retrn
EGRX EAGLE PHARMACT 81.83 -6.51% 97.51%
AZN ASTRAZENECA PLC 31.3 0.64% 11.75%
HCA HCA HOLDINGS 83.17 -10.34% 8.08%
BIIB BIOGEN INC 275.41 -17.61% 7.90%
ANIP ANI PHARMACEUT 45.54 -13.30% 38.04%

Top-Five Medical Sector Stocks--Most Overvalued

Ticker Company Name Market Price Valuation Last 12-M Retrn
ICPT INTERCEPT PHARM 115.8 300.00% -5.59%
TSRO TESARO INC 153.62 269.32% 233.59%
AKAO ACHOGEN INC 20.3 223.89% 574.42%
DEPO DEPOMED INC 14.84 207.30% 12.94%
CYH COMMNTY HLTH SY 8.7 195.72% -51.04%
 Find out what Wall Street Investment and Media Professionals already know,
ValuEngine offers sophisticated stock valuation and forecast research as well as a
variety of portfolio screening and creation tools.

Free Download for Readers

As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports
Intel Corporation (INTC) is one of the world's largest semiconductor chip maker. The
Company develops advanced integrated digital technology products, primarily
integrated circuits, for industries such as computing and communications. It also
develops platforms, which it defines as integrated suites of digital computing
technologies that are designed and configured to work together to provide an
optimized user computing solution compared to components that are used
separately. Intel designs and manufactures computing and communications
components, such as microprocessors, chipsets, motherboards, and wireless and
wired connectivity products, as well as platforms that incorporate these components.
The Company sells its products primarily to original equipment manufacturers, original
design manufacturers, PC and network communications products users, and other
manufacturers of industrial and communications equipment. Intel Corporation is
based in Santa Clara, California.
VALUENGINE RECOMMENDATION: ValuEngine continues its BUY recommendation on
INTEL CORP for 2017-03-23. Based on the information we have gathered and our
resulting research, we feel that INTEL CORP has the probability to OUTPERFORM
average market performance for the next year. The company exhibits ATTRACTIVE
Company Size and P/E Ratio.
You can download a free copy of detailed report on Intel Corporation (INTC) from
the link below.
Read our Complete Rating and Forecast Report on Intel (INTC) HERE.
 ValuEngine Forecast
Target Expected
Price* Return
1-Month 35.46 0.54%
3-Month 35.82 1.56%
6-Month 35.87 1.71%
1-Year 37.55 6.46%
2-Year 38.95 10.44%
3-Year 39.15 11.00%

Valuation & Rankings

Valuation 6.80% Valuation Rank(?) 53
overvalued
1-M Forecast 1-M Forecast
0.54%
Return Return Rank 86
Momentum
12-M Return 10.22% 45
Rank(?)
Sharpe Ratio
Sharpe Ratio 0.29 68
Rank(?)
5-Y Avg Annual 5-Y Avg Annual Rtn
5.95% 64
Return Rank
Volatility 20.41% Volatility Rank(?) 70
Expected EPS
-0.24% EPS Growth Rank(?) 21
Growth
Market Cap
170.53 Size Rank
(billions) 100

Trailing P/E Ratio 12.63 Trailing P/E Rank(?)

86
Forward P/E Ratio
Forward P/E Ratio 12.66 73
Rank
PEG Ratio n/a PEG Ratio Rank n/a
Price/Sales 2.87 Price/Sales Rank(?) 37
Market/Book
Market/Book 4.00 32
Rank(?)
Beta 1.03 Beta Rank 39
Alpha -0.01 Alpha Rank 43
 ValuEngine.com is an Independent Research Provider (IRP), producing
buy/hold/sell recommendations, target price, and valuations on over 5,000
US and Canadian equities every trading day.

Contact ValuEngine at (800) 381-5576 or support@valuengine.com

Visit www.ValuEngine.com for more information

ValuEngine Capital Management LLC is a Registered Investment Advisory

(RIA) firm that trades client accounts using ValuEngine's award-winning
stock research.

Contact ValuEngine Capital at info@valuenginecapital.com

Visit www.ValuEngineCapital.com for more information